Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study of Surgical Interventions in Fistulizing Conditions
NCT04940611 · View on ClinicalTrials.gov ↗
Study Summary
In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The aim of the study is to generate real-world evidence on standard of care for surgical interventions and related outcomes when treating complex fistulizing conditions. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study.
Conditions Studied
Study Locations (20)
Other
- AKH - Medizinische Universitat Wien — Vienna
- UZ Antwerpen — Antwerp
- Cliniques Universitaires Saint-Luc — Brussels
- Jessa Ziekenhuis Hospital — Hasselt
- Clinique CHC MontLegia — Liège
- AZ Delta — Roeselare
Florida
- Baptist MD Anderson Cancer Center — Jacksonville
- University of South Florida - PARENT — Tampa
Pennsylvania
- Penn Medicine PA — Philadelphia
- Temple University Hospital — Philadelphia
Texas
- Baylor Research Institute — Dallas
- Colon & Rectal Clinic — Houston
California
- Cedars-Sinai Medical Center — Los Angeles
Kansas
- University of Kansas Medical Center Research Institute, Inc. — Kansas City
Louisiana
- GI Alliance - Baton Rouge — Baton Rouge
New York
- Lenox Hill Hospital PRIME — New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2026-05-02 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04940611
The ClinicalTrials.gov registry entry for NCT04940611 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 387 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 5 conditions, with Crohns Disease appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04940611 reports 20 study locations spanning 12 distinct geographic areas — top geographies include Other, Florida, Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04940611 about?
NCT04940611 is a clinical study titled "A Study of Surgical Interventions in Fistulizing Conditions". In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The aim of the study is to generate real-world evidence on standard of care for surgical interventions and related outcomes when treating comple...
What is the current status of trial NCT04940611?
This trial is currently active not recruiting. The enrollment target is 750 participants. The study started on 2021-08-05. Estimated completion is 2026-05-02.
What conditions does trial NCT04940611 study?
This clinical trial studies the following conditions: Crohns Disease, Fistula, Complex Perianal Fistula, Rectovaginal Fistula, Complex Cryptoglandular Fistula. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT04940611?
This trial is sponsored by Takeda, which has 387 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04940611 being conducted?
This trial has 20 study locations across California, Florida, Kansas, Louisiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.